Cathay Capital, OrbiMed exit French diagnostics firm Echosens

Photo: Echosens' Facebook page

Cathay Capital Private Equity and healthcare-dedicated investment firm OrbiMed have exited their investments in French medical diagnostic equipment company Echosens to European private equity firm (PE) firm Astorg for an undisclosed amount.

The latest transaction sees Astorg become a stakeholder in the company, alongside Chinese pharmaceutical company Inner Mongolia FuRui, which remains the reference shareholder, according to a statement issued last week.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter